The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 15, 2016

Filed:

Jul. 22, 2010
Applicants:

Jens Stechl, Frankfurt am Main, DE;

Angele Moryusef, Bridgewater, NJ (US);

Christophe Gaudin, Paris, FR;

Pascale Ythier-moury, Paris, FR;

Inventors:

Jens Stechl, Frankfurt am Main, DE;

Angele Moryusef, Bridgewater, NJ (US);

Christophe Gaudin, Paris, FR;

Pascale Ythier-Moury, Paris, FR;

Assignee:

SANOFI, Paris, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4418 (2006.01); A61K 31/4409 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4409 (2013.01); A61K 31/4418 (2013.01); Y10S 514/822 (2013.01);
Abstract

The invention relates to the use of (2R,3R)-2-(3-carbamimidoyl-benzyl)-3-[4-(1-oxy-pyridin-4-yl)benzoylamino]-butyric acid methyl ester or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in non-ST elevation myocardial infarction, said treatment comprising administering a therapeutically effective amount of (2R,3R)-2-(3-Carbamimidoyl-benzyl)-3-[4-(1-oxy-pyridin-4-yl)benzoylamino]-butyric acid methyl ester or a pharmaceutically acceptable salt thereof to a human patient, who is elderly and/or shows renal insufficiency and/or has a low body weight.


Find Patent Forward Citations

Loading…